Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group

International Journal of Stroke

Volumn 3, Issue 1, 2008, Pages 63-65

  Dorhout Mees, Sanne M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Clinical protocols; Controlled clinical trial; Intracranial aneurysm; Magnesium; Neuro protection; Subarachnoid hemorrhage

Indexed keywords

MAGNESIUM SULFATE; NIMODIPINE; PLACEBO;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; MULTICENTER STUDY; NETHERLANDS; OUTCOME ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; RISK REDUCTION; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

ANEURYSM, RUPTURED; ANTI-ARRHYTHMIA AGENTS; HUMANS; INTRACRANIAL ANEURYSM; MAGNESIUM SULFATE; SUBARACHNOID HEMORRHAGE;

EID: 38949151572     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2008.00168.x     Document Type: Article

References (13)

1. Hop JW, Rinkel GJ, Algra A, van Gijn J: Case-fatality rates and functional outcome after subarachnoid hemorrhage: A systematic review. Stroke 1997; 28:660-4.
2. Brilstra EH, Rinkel GJ, Algra A, van Gijn J: Rebleeding, secondary ischemia, and timing of operation in patients with subarachnoid hemorrhage. Neurology 2000; 55:1656-60.
3. Roos YB, de Haan RJ, Beenen LF, Groen RJ, Albrecht KW, Vermeulen M: Complications and outcome in patients with aneurysmal subarachnoid haemorrhage: A prospective hospital based cohort study in the Netherlands. J Neurol Neurosurg Psychiatry 2000; 68:337-41.
4. McLean RM: Magnesium and its tAerapeutic uses: a review. Am J Med 1994; 96:63-76.
5. Altman D, Carolli G, Duley L et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: A randomised placebo-controlled trial. Lancet 2002; 359:1877-90.
6. Belfort MA, Anthony J, Saade GR, Allen JC Jr: A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia. N Engl J Med 2003; 348:304-11.
7. van den Bergh WM, Dijkhuizen RM, Rinkel GJ: Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 2004; 17:301-13.
8. van den Bergh WM, Algra A, van Kooten F et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: A randomized controlled trial. Stroke 2005; 36:1011-15.
9. Dorhout Mees S, Rinkel G, Feigin V et al. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev; 2007; CD000277.
10. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ: Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 2003; 145:195-9.
11. van Norden AG, van den Bergh WM, Rinkel GJ: Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage. J Clin Pharm Ther 2005; 30:439-42.
12. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988; 19:604-7.
13. Newcommon NJ, Green TL, Haley E, Cooke T, Hill MD: Improving the assessment of outcomes in stroke: Use of a structured interview to assign grades on the modified Rankin Scale. Stroke 2003; 34:377-8.